CORC  > 中国医学科学院 北京协和医学院
Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens
Meng, Zhilan; Lu, Junliang; Wu, Huanwen; Zhao, Yu; Luo, Yufeng; Gao, Jie; Zhu, Qingli; Jiang, Yuxin; Li, Wenbo; Liang, Zhiyong
2016
卷号37期号:1页码:611-618
关键词BRAF CD117 Immunocytochemistry Fine-needle aspiration Papillary thyroid carcinoma
ISSN号1010-4283
DOI10.1007/s13277-015-3837-9
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6382025
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Meng, Zhilan,Lu, Junliang,Wu, Huanwen,et al. Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens[J],2016,37(1):611-618.
APA Meng, Zhilan.,Lu, Junliang.,Wu, Huanwen.,Zhao, Yu.,Luo, Yufeng.,...&Liang, Zhiyong.(2016).Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.,37(1),611-618.
MLA Meng, Zhilan,et al."Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens".37.1(2016):611-618.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace